News
AI Summary
21 Jul 20267 Safar 1448 AH
Bristol Myers Squibb buys Nvidia AI system for drug discovery

Bristol Myers Squibb buys Nvidia AI system for drug discovery

Bristol Myers Squibb has announced its acquisition of an Nvidia DGX SuperPOD built on the Vera Rubin architecture, becoming the first life sciences group to do so. The new cluster will consist of eight DGX Vera Rubin NVL72 systems, integrating Nvidia's CPU and GPU technologies. This infrastructure will be utilized to train proprietary models and run predictions across various research programs.

Follow these topics

Sign in to follow the topics that matter to you

Sign in to follow

This summary is generated with AI and receives periodic editorial review. Refer to the original source for full details.

0
0 reading now

Insight Score

Rate to unlock

Sign in to react, rate, and save. Sign In